The Maternal, Infant, and Early Childhood Home Visiting program is authorized and funded for five years at $1.5 billion. The investment supports improvements in health and development outcomes for at-risk children through evidence-based home visiting programs. Three percent of the funding each year is set aside for Tribal grantees and three percent is set aside each year for research and evaluation activities. Funding is appropriated as follows:
Grants are subject to the condition that the state or territory assigns service priority to families residing in at-risk communities as identified by the statewide needs assessment. The program is administered by HRSA in collaboration with the Administration for Children and Families.
FY 2015 Awards
In 2015, HRSA awarded $386 million to states, territories, and nonprofit organizations. $116.6 million in formula grants was awarded to 53 states and territories, $260.8 million in competitive grants to 32 states, and $8.4 million in formula grants to three nonprofit organizations to support the continuation of evidence-based home visiting services in Florida, North Dakota and Wyoming.
FY 2014 Awards
In 2014, HRSA awarded $357 million to states, territories, and nonprofit organizations; $118 million by formula, and $239 million by competition to those states that have sufficiently demonstrated the interest and capacity to expand and/or to enhance the development of their home visiting efforts.
FY 2013 Awards
In 2013, HRSA awarded $341 million to states, territories, and nonprofit organizations; $130 million by formula and $211 million by competition. Competitive funding was awarded through Expansion Grants ($204 million) to 31 states to expand their home visiting services and through Development Grants ($7 million) to four states to build on existing home visiting efforts.
FY 2012 Awards
In 2012, HRSA awarded $309 million to states, territories, and nonprofit organizations; $119 million by formula and $190 million by competition. Competitive funding was awarded through Expansion grants ($143 million) to 19 states to expand their home visiting services and through Development Grants ($46 million) to 19 states to build on existing home visiting efforts.
FY 2011 Awards
In September 2011, HRSA awarded a total of $224 million to states and territories; $124 million by formula and $100 million by competition. Competitive funding was awarded through Expansion Grants ($66 million) to nine states and Development Grants ($34 million) to 13 states.
FY 2010 Awards
In 2010, HRSA awarded $92 million to states by formula to begin to plan for implementation of home visiting programs. States identified their at-risk communities and determined which of these at-risk communities would receive home visiting services, as well as developed their measures and data collection systems for demonstrating improvements in the six benchmark areas.
Note: Year award amounts include state, territory, and non-profit grant obligations only and do not include obligations for tribal grants, research, evaluation, technical assistance, and federal administration. Award amounts represent obligations as of fiscal year end; therefore, deobligations occurring in subsequent fiscal years are not included.
The MIECHV Research Program supports applied research relating to evidence-based home visiting programs and strategies that have the potential to improve the health, development, and well-being of mothers, young children, and their families. Findings from the research supported by the MIECHV Research Program are expected to have potential for application in improving home visiting services for mothers and children.
The Home Visiting Research program in 2012 made three awards to Lehigh University, University of Kansas, and Washington University in St. Louis.
In 2012, the MIECHV Research Network cooperative agreement was awarded to Johns Hopkins University to support the creation of an interdisciplinary, multicenter research forum for scientific collaboration and infrastructure-building related to home visiting research that is designed to improve life outcomes among mothers, infants, and young children.